AMAG Pharmaceuticals Announces Grant of Inducement Awards Under NASDAQ Listing Rule 5635(c)(4)
August 20 2019 - 8:00AM
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that the
Board of Directors of AMAG approved inducement awards to a new
employee of (i) an option to purchase 16,700 shares of common stock
and (ii) 8,500, restricted stock units. The option will have an
exercise price equal to the closing price of AMAG’s common stock on
the grant date and will be exercisable in four equal annual
installments beginning on the first anniversary of August 19, 2019
(the grant date). The option will have a ten-year term and be
subject to the terms and conditions of the stock option agreement
pursuant to which the option will be granted. The restricted stock
units will vest in three equal annual installments beginning on the
first anniversary of the grant date and will be subject to the
restricted stock unit agreement pursuant to which the restricted
stock units will be granted. These equity awards will be granted
without stockholder approval as inducements material to the
employee entering into employment with AMAG in accordance with
NASDAQ Listing Rule 5635(c)(4).
About AMAG AMAG is a pharmaceutical company
focused on bringing innovative products to patients with unmet
medical needs. The company does this by leveraging its development
and commercial expertise to invest in and grow its pharmaceutical
products across a range of therapeutic areas, including women’s
health. For additional company information, please
visit www.amagpharma.com.
AMAG Pharmaceuticals® is a registered trademark of AMAG
Pharmaceuticals, Inc.
AMAG Pharmaceuticals Contacts: Investors: Linda
Lennox908-627-3424
Media: Sarah Connors 781-296-0722
AMAG Pharmaceuticals (NASDAQ:AMAG)
Historical Stock Chart
From Aug 2024 to Sep 2024
AMAG Pharmaceuticals (NASDAQ:AMAG)
Historical Stock Chart
From Sep 2023 to Sep 2024